| Time | Topic | Speaker | Chairperson |
|---|---|---|---|
|
09:00-09:30 |
Innaguration |
Prof. (Dr) Ashutosh Biswas, Prof. (Dr) DK Parida Prof. (Dr) SK Das Majumdar, Dr. Sandip Kumar Barik Dr. Sourav Kumar Mishra, Dr. Phanindra kumar Swain Dr. Deepak Kumar Das |
|
|
09:30-10:00 |
Radiotherapy as an Immune Primer: Mechanisms, Signals, and Clinical Translation. |
Dr.Shamsudheen Cholayil |
Dr. Partha Mukhopadhyay Dr. S N Senapati Dr. Kshitish Mishra |
|
10:00-10:20 |
Dose, Fractionation for Immunogenic Radiotherapy |
Dr. T Ganesh |
Dr. Siddhartha Nanda Dr. Rahul Sharma Dr. Ranjit kar Dr. Nilam Singh |
|
10:20-10:40 |
SBRT in an Immunogenic Context |
Dr. Kumar Swamy |
Dr. Sovan S Dhar Dr. Lucy Pattanayak Dr. Sanjukta Padhi |
|
10:40-11:00 |
Pembrolizumab for biliary Tract Cancer-Current Evidence and Clinical Perspective |
Dr. Soumya S Panda |
|
|
11:00-11:20 |
Tea Break |
||
|
11:20-11:40 |
Perioperative Immunotherapy in Gastroesophageal Cancer |
Dr. Chinmayee Pani |
Dr. Ranjan Kumar Mohanty Dr. Dillip Kar Dr. Dillip Muduly |
|
11:40- 12:00 |
First-Line Immunotherapy Across Tumors: Are We Replacing Chemotherapy ? |
Dr. T P Sahoo |
Dr. Ranjan Mohapatra Dr. G Biswas Dr. Shaikh Iftikar Ali Dr. Avinash Badajena |
|
12:00 – 12:20 |
Non-Squamous NSCLC: the way forward. The breakthrough of Immunotherapy |
Dr. Prasant parida |
|
|
12:20 – 12:40 |
Serplulimab: The Next Gen IO |
Dr. Goutam Santosh panda |
Dr. Ganesh Subudhi Dr. Arya Banidutta |
|
12:40 – 01:00 |
Management of Immunotherapy Induced Pneumonitis |
Dr. Sourav Mishra |
Dr. P R Mohapatra Dr. Sourin Bhuniya Dr. Sushant Paikray Dr. Durga Prasad Sahoo |
|
01:00 – 02:00 |
Lunch |
||
|
02:00 – 02:30 |
Radiation Therapy with Checkpoint Inhibitors in H & N Cancer |
Dr. Rajiv Ranjan Prasad |
Dr. Mahesh Sultania Dr. Tapan Sahoo Dr. Sulagna Mohanty Dr. Samarendra Das |
|
02:30- 02:50 |
Nivolumab-Journey from metastatic to Early Settings |
Dr. Shivam Singla |
Dr. Sanjib Mishra Dr. Ranjan Mohapatra  |
|
02:50- 03:20 |
Optimizing HCC Outcomes: Leveraging Key Insights from Checkmate 9DW |
Dr.Sourav Mishra |
Dr. Jogamaya Pattnik Dr. Manas Panigrahi |
|
03:20- 03:30 |
Redefining the treatment Paradigm in IDH-mutant Glioma: Percision targeting with Vorasidenib |
Dr. Avinash Pandey |
Dr. R N Sahoo Dr. Prasant Parida Dr. Saroj Das |
|
03:40- 04:00 |
Tea Break |
||
|
04:00 – 04:20 |
Survival Impact of Dostarlimab in 1L Ednometrial Cancer |
Dr. Priya Nayak |
Dr. Dipti Samant Dr. Niharika Panda Dr. Sthiti Das |
|
04:20 – 04:40 |
The Evolving Role of Immunotherapy in Locally Advanced Cervical Cancer |
Dr. Ghanashyam Biswas |
|
|
04:40 – 05:00 |
Redefining PD-L1 thresholds in mTNBC: Expanding the role of Immunotherapy |
Dr. T P Sahoo |
Dr. Tushar S Mishra Dr.Asit Mohanty Dr. Sandeep Muzumdar  |
|
05:00 – 05:20 |
Management of Immune related cutaneous Toxicity |
Dr. Arpita Nibedita Rout |
Dr. Sachin Biswal Dr. Aditya Mishra Dr. Lal Mohan Soy Dr. Srigopal Mohanty |
|
05:20 – 05:40 |
Management of immune related GI Toxicity |
Dr. Manas Panigrahi |
Dr. Prakash Swain Dr. Chira Khadanga Dr. Sanjay Mishra Dr. Sunil Agarwal |
|
05:40 Onwards |
Immuno Connect Quiz for Residents |
|
|